Magdalena Dziadzio

Losartan therapy for Raynaud's phenomenon and scleroderma: Clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial

Magdalena Dziadzio, Christopher P. Denton, Roy E. Smith et al. · Arthritis & Rheumatism · 1999 · 312 citations · Full text

COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

Adrian Shields, Siobhan O. Burns, Sinisa Savic et al. · Journal of Allergy and Clinical Immunology · 2020 · 234 citations · Full text

Primary Immunodeficiency, Secondary Immunodeficiency, United Kingdom Experience +7

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels

Atfa Sassi, Sandra Lazaroski, Gang Wu et al. · Journal of Allergy and Clinical Immunology · 2014 · 188 citations · Full text

Serum Ige Levels, Immunogenetics, Allergy +10

N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma

Magdalena Dziadzio, William R. Usinger, Andrew Leask et al. · QJM · 2005 · 98 citations

Circulating levels of active transforming growth factor β1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score

Magdalena Dziadzio, Roy E. Smith, David Abraham et al. · Lara D. Veeken · 2005 · 59 citations · Full text